ESRRG and breast cancer: In addition, miR-378 affects the TCA cycle in breast cancer by modulating the expression of peroxisome proliferator-activated receptor-alpha, GA binding protein transcription factor, subunit (GABPA), co-activator 1-alpha (PGC-1α), and estrogen-related receptor gamma (ERRγ) (152).